US EditionNASA-inspired low-vibration belt lowers bone fracture risk
- Last year, the FDA approved Osteoboost, a low-vibration belt device designed to treat osteopenia, a condition of low bone density.
- Osteopenia mainly affects postmenopausal women, with 54% of them affected, and often leads to osteoporosis and fractures if untreated.
- Osteoboost is a non-invasive, wearable prescription device proven in clinical trials to reduce bone loss by 85% on average in participants.
- The device costs $995 without insurance coverage, and while doctors prescribe it mainly to women aged 52–57, Bone Health Technologies is working to expand coverage.
- Users like Corn, diagnosed at 40 and now 55, have used Osteoboost for a month, reflecting growing efforts to prevent bone loss and fractures in aging women.
Insights by Ground AI
Does this summary seem wrong?
24 Articles
24 Articles
All
Left
2
Center
18
Right
1
The Sun (Lowell)+23 Reposted by 23 other sources
NASA-inspired low-vibration belt lowers bone fracture risk
For some, Osteoboost might initially evoke TV informercials for gadgets that promise to shock people’s abdominal muscles into six-pack formation while they sit, or mid-20th century contraptions that professed to jiggle away fat without exercise. But this device, a low-vibration belt that resembles a fanny pack, received approval last year from the U.S. Food and Drug Administration. It just hit the market as the first and only non-drug interventi…
·Lowell, United States
Read Full ArticleCoverage Details
Total News Sources24
Leaning Left2Leaning Right1Center18Last UpdatedBias Distribution86% Center
Bias Distribution
- 86% of the sources are Center
86% Center
C 86%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
